biotechhedge-----alot has changed since that post. one harvey got a very good deal on rida. aria could never have kept up with mrk combo plans. you saying it should already been approved ??????? i dont know what your saying there.
as for partnering 534 they very well may, but the time is not now were more then capable and have the money to start the trial. it should be very easy trial to design. the upfront money will go up1-2 times more 6-12 months down the road. then we very well may partner.
hang in there and have little patience, aria is company that is growing up here, most biotech companies much larger then us would love to have the 3 drugs we do.
also keep in mind fidelity why did they buy so much???
well they probably view this as very good longterm investment
goodluck
dough
News 
Market Data 
Discover 
AI
